General Inquiries Contact Us We look forward to connecting with you! Please choose from one of the following ways to contact us: 1-800 Information Line To connect with a knowledgeable […]

Romosozumab EVENITY™ (romosozumab injection) Romosozumab, a sclerostin inhibitor, is the first new approach to the treatment of osteoporosis and fracture risk in almost a decade.Romosozumab (EVENITY™) significantly and rapidly (over […]

If you are on medication for osteoporosis, are you ever tempted to stop taking it? If your answer is yes, you are not alone. Studies indicate that especially for those […]

SAC Members and Research MD, PHD LaetitiaMichou Dr. Michou has completed her medicine studies at the University of Angers (France), her Rheumatology residency at the Denis Diderot-Paris VII University (France) […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

We are aware of a recent Food and Drug Administration (FDA) publication that reports on the association between use of zoledronic acid (Aclasta) and renal impairment. 1 We recognize that […]

GET SUPPORT Support Resources Osteoporosis Canada currently produces publications in various languages. LEARN MORE Let’s Talk The information line gives you access to trained and compassionate staff and volunteers who […]

SUPPORT LINE To Speak With A Trained Volunteer Counsellor About Osteoporosis Call Our Information-Line: Toll-free: 1-800-463-6842 (in Canada only) The information line gives you access to knowledgeable and understanding people […]

Upon his retirement in 2006 from his position with the federal government, Larry turned his attention to learning more about osteoporosis. His quest for answers and information he could trust led him to the Canadian Osteoporosis Patient Network and Osteoporosis Canada.